Widespread amphotericin B-resistant strains of Aspergillus fumigatus in Hamilton, Canada

References

• Dagenais TR, Keller NP. Pathogenesis of Aspergillus fumigatus in Invasive Aspergillosis. Clin Microbiol Rev. 2009;22(3):447–465.
   PubMed Web of Science ®Google Scholar
• Maturu VN, Agarwal R. Itraconazole in chronic pulmonary aspergillosis: In whom, for how long, and at what dose? Lung India. 2015;32(4):309–312.
   PubMed Web of Science ®Google Scholar
• Agarwal R. Allergic bronchopulmonary aspergillosis. Chest. 2009; 135(3):805–826.
   PubMed Web of Science ®Google Scholar
• Segal BH, Walsh TJ. Current approaches to diagnosis and treatment of invasive aspergillosis. Am J Respir Crit Care Med. 2006;173(7):707–717.
   PubMed Web of Science ®Google Scholar
• Patterson TF, Thompson GR, Denning DW, et al. Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;63(4):e1–e60.
   PubMed Web of Science ®Google Scholar
• Verweij PE, Chowdhary A, Melchers WJ, Meis JF. Azole resistance in Aspergillus fumigatus: can we retain the clinical use of mold-active antifungal azoles? Clin Infect Dis. 2016;62(3):362–368.
   PubMed Web of Science ®Google Scholar
• Ashu EE, Kim GY, Roy-Gayos P, et al. Limited evidence of fungicide-driven triazole-resistant Aspergillus fumigatus in Hamilton, Canada. Can J Microbiol. 2018;64(2):119–130.
   PubMed Web of Science ®Google Scholar
• Verweij PE, Ananda-Rajah M, Andes D, et al. International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus. Drug Resist Updat. 2015;21-22:30–40.
   PubMed Web of Science ®Google Scholar
• vanden Bossche H, Warnock DW, Dupont B, et al. Mechanisms and clinical impact of antifungal drug resistance. J Med Vet Mycol. 1994;32 Suppl 1:189–202.
   Google Scholar
• Blum G, Perkhofer S, Haas H, et al. Potential basis for amphotericin B resistance in Aspergillus terreus. Antimicrob Agents Chemother. 2008;52(4):1553–1555.
   PubMed Web of Science ®Google Scholar
• Gonçalves SS, Stchigel AM, Cano J, Guarro J, Colombo AL. In vitro antifungal susceptibility of clinically relevant species belonging to Aspergillus section Flavi. Antimicrob Agents Chemother. 2013;57(4):1944–1947.
   PubMed Web of Science ®Google Scholar
• Dannaoui E, Meletiadis J, Tortorano AM, et al. Susceptibility testing of sequential isolates of Aspergillus fumigatus recovered from treated patients. J Med Microbiol. 2004;53(Pt 2):129–134.
   PubMed Web of Science ®Google Scholar
• Moosa MY, Alangaden GJ, Manavathu E, Chandrasekar PH. Resistance to amphotericin B does not emerge during treatment for invasive aspergillosis. J Antimicrob Chemother. 2002;49(1):209–213.
   PubMed Web of Science ®Google Scholar
• Manavathu EK, Alangaden GJ, Chandrasekar PH. In-vitro isolation and antifungal susceptibility of amphotericin B-resistant mutants of Aspergillus fumigatus. J Antimicrob Chemother. 1998;41(6):615–619.
   PubMed Web of Science ®Google Scholar
• Reichert-Lima F, Lyra L, Pontes L, et al. Surveillance for azoles resistance in Aspergillus spp. highlights a high number of amphotericin B-resistant isolates. Mycoses. 2018;61(6):360-365.
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard. 2nd ed. Wayne, PA, USA: CLSI; 2002:M38–A2.
   Google Scholar
• Espinel-Ingroff A, Cuenca-Estrella M, Fothergill A, et al. Wild-type MIC distributions and epidemiological cutoff values for amphotericin B and Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document. Antimicrob Agents Chemother. 2011;55(11):5150–5154.
   PubMed Web of Science ®Google Scholar
• Elefanti A, Mouton JW, Verweij PE, Zerva L, Meletiadis J. Susceptibility breakpoints for amphotericin B and Aspergillus species in an in vitro pharmacokinetic-pharmacodynamic model simulating free-drug concentrations in human serum. Antimicrob Agents Chemother. 2014;58(4):2356–2362.
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. Epidemiological Cutoff Values for Antifungal Susceptibility Testing. CLSI supplement M59. 2nd ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2018.
   Google Scholar
• Iwase T, Tajima A, Sugimoto S, et al. A simple assay for measuring catalase activity: a visual approach. Sci Rep. 2013;3:3081.
   PubMed Web of Science ®Google Scholar
• Kelly SL, Lamb DC, Kelly DE, et al. Resistance to fluconazole and cross-resistance to amphotericin B in Candida albicans from AIDS patients caused by defective sterol delta5,6-desaturation. FEBS Lett. 1997;400(1):80–82.
   PubMed Web of Science ®Google Scholar
• Joseph-Horne T, Hollomon D, Loeffler RS, Kelly SL. Cross-resistance to polyene and azole drugs in Cryptococcus neoformans. Antimicrob Agents Chemother. 1995;39(7):1526–1529.
   PubMed Web of Science ®Google Scholar
• Forastiero A, Mesa-Arango AC, Alastruey-Izquierdo A, et al. Candida tropicalis antifungal cross-resistance is related to different azole target (Erg11p) modifications. Antimicrob Agents Chemother. 2013;57(10):4769–4781.
   PubMed Web of Science ®Google Scholar
• Dannaoui E, Persat F, Monier MF, Borel E, Piens MA, Picot S. In-vitro susceptibility of Aspergillus spp. isolates to amphotericin B and itraconazole. J Antimicrob Chemother. 1999;44(4):553–555.
   PubMed Web of Science ®Google Scholar
• Araujo R, Pina-Vaz C, Rodrigues AG. Susceptibility of environmental versus clinical strains of pathogenic Aspergillus. Int J Antimicrob Agents. 2007;29(1):108–111.
   PubMed Web of Science ®Google Scholar
• Guinea J, Peláez T, Alcalá L, Ruiz-Serrano MJ, Bouza E. Antifungal susceptibility of 596 Aspergillus fumigatus strains isolated from outdoor air, hospital air, and clinical samples: analysis by site of isolation. Antimicrob Agents Chemother. 2005;49(8):3495–3497.
   PubMed Web of Science ®Google Scholar
• Purkait B, Kumar A, Nandi N, et al. Mechanism of amphotericin B resistance in clinical isolates of Leishmania donovani. Antimicrob Agents Chemother. 2012;56(2):1031–1041.
   PubMed Web of Science ®Google Scholar
• Brandon M, Howard B, Lawrence C, Laubenbacher R. Iron acquisition and oxidative stress response in Aspergillus fumigatus. BMC Syst Biol. 2015;9:19.
   PubMed Web of Science ®Google Scholar